ロード中...
Biomarkers of the Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
The mechanisms underlying the resistance to immune checkpoint inhibitors (ICIs) therapy in metastatic urothelial carcinoma (mUC) patients are not clear. It is of great significance to discern mUC patients who could benefit from ICI therapy in clinical practice. In this study, we performed machine le...
保存先:
| 出版年: | Front Immunol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7477044/ https://ncbi.nlm.nih.gov/pubmed/32983112 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.01900 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|